Safety, blood levels & effects of ALN-TTR02 in Japanese volunteers; v1

• Research type

  Research Study

• Full title

  A Phase 1, Randomized, Double-blind, Placebo-Controlled, Single Ascending Dose, Safety, Tolerability and Pharmacokinetics Study of ALN-TTR02 in Japanese Healthy Volunteers. HMR code (13-016)

• IRAS ID

  143480

• Contact name

  Frans van den Berg

• Contact email

  vparker@hmrlondon.com

• Sponsor organisation

  Alnylam Pharmaceuticals Inc

• Eudract number

  2013-004053-24

• Clinicaltrials.gov Identifier

  NCT02053454

• REC name

  Scotland A REC

• REC reference

  13/SS/0218

• Date of REC Opinion

  11 Dec 2013

• REC opinion

  Further Information Favourable Opinion